BACKGROUND: Childhood asthma can have a range of outcomes in adulthood. OBJECTIVE: To identify clinical features and exposures associated with persistence and severity of childhood asthma in adulthood. METHODS: Eighty-five of 121 subjects previously enrolled in a study of immunotherapy for childhood allergic asthma (age 5-12 years) were re-evaluated with allergy skin testing, spirometry, and interviews about asthma symptoms and medications. These young adults (age 17-30 years; 74% male) all had moderate to severe childhood asthma. Adult asthma severity was scored by using a modified version of National Heart, Lung, and Blood Institute severity categories. RESULTS: Thirteen (15.3%) of 85 adult subjects were in remission despite persistent childhood asthma. Another 19 subjects (22.4%) had only intermittent asthma. The remaining 53 had persistent asthma, of whom 12 (14.1%) had mild asthma, 25 (29.4%) had moderate asthma, and 16 (18.8%) had severe asthma. Subjects in remission, compared with subjects with intermittent or persistent asthma, had lower total serum IgE in childhood (412 ng/mL vs 1136 ng/mL vs 968 ng/mL; P = .02) and fewer positive allergy skin tests (7 vs 9 vs 10 from panel of 18; P = .02). Subjects in remission also had milder childhood asthma, indicated by lower average daily medication usage scores (1.6 vs 3.5 vs 4.4; P = .005) and lower percentage of days on inhaled corticosteroids (13.7% vs 24.7% vs 40.9%; P = .008). No significant association was found between current asthma severity and childhood immunotherapy ( P = .46). CONCLUSION: The prognosis of childhood allergic asthma in adulthood is largely determined early in life. The degree of atopy appears to be a critical determinant of asthma persistence.
BACKGROUND: Childhood asthma can have a range of outcomes in adulthood. OBJECTIVE: To identify clinical features and exposures associated with persistence and severity of childhood asthma in adulthood. METHODS: Eighty-five of 121 subjects previously enrolled in a study of immunotherapy for childhood allergic asthma (age 5-12 years) were re-evaluated with allergy skin testing, spirometry, and interviews about asthma symptoms and medications. These young adults (age 17-30 years; 74% male) all had moderate to severe childhood asthma. Adult asthma severity was scored by using a modified version of National Heart, Lung, and Blood Institute severity categories. RESULTS: Thirteen (15.3%) of 85 adult subjects were in remission despite persistent childhood asthma. Another 19 subjects (22.4%) had only intermittent asthma. The remaining 53 had persistent asthma, of whom 12 (14.1%) had mild asthma, 25 (29.4%) had moderate asthma, and 16 (18.8%) had severe asthma. Subjects in remission, compared with subjects with intermittent or persistent asthma, had lower total serum IgE in childhood (412 ng/mL vs 1136 ng/mL vs 968 ng/mL; P = .02) and fewer positive allergy skin tests (7 vs 9 vs 10 from panel of 18; P = .02). Subjects in remission also had milder childhood asthma, indicated by lower average daily medication usage scores (1.6 vs 3.5 vs 4.4; P = .005) and lower percentage of days on inhaled corticosteroids (13.7% vs 24.7% vs 40.9%; P = .008). No significant association was found between current asthma severity and childhood immunotherapy ( P = .46). CONCLUSION: The prognosis of childhood allergic asthma in adulthood is largely determined early in life. The degree of atopy appears to be a critical determinant of asthma persistence.
Authors: Torie Grant; Charles Aloe; Matthew Perzanowski; Wanda Phipatanakul; Mary E Bollinger; Rachel Miller; Elizabeth C Matsui Journal: J Allergy Clin Immunol Pract Date: 2016-12-05
Authors: Nadia N Hansel; Elizabeth C Matsui; Robert Rusher; Meredith C McCormack; Jean Curtin-Brosnan; Roger D Peng; Derek Mazique; Patrick N Breysse; Gregory B Diette Journal: J Asthma Date: 2011-08-23 Impact factor: 2.515
Authors: Ronina A Covar; Robert Strunk; Robert S Zeiger; Laura A Wilson; Andrew H Liu; Scott Weiss; James Tonascia; Joseph D Spahn; Stanley J Szefler Journal: J Allergy Clin Immunol Date: 2010-02 Impact factor: 10.793
Authors: Demetra Z Rotsides; Inge F Goldstein; Stephen M Canfield; Matthew Perzanowski; Robert B Mellins; Lori Hoepner; Maxine Ashby-Thompson; Judith S Jacobson Journal: Respir Med Date: 2009-11-13 Impact factor: 3.415
Authors: Stephan Weidinger; Christian Gieger; Elke Rodriguez; Hansjörg Baurecht; Martin Mempel; Norman Klopp; Henning Gohlke; Stefan Wagenpfeil; Markus Ollert; Johannes Ring; Heidrun Behrendt; Joachim Heinrich; Natalija Novak; Thomas Bieber; Ursula Krämer; Dietrich Berdel; Andrea von Berg; Carl Peter Bauer; Olf Herbarth; Sibylle Koletzko; Holger Prokisch; Divya Mehta; Thomas Meitinger; Martin Depner; Erika von Mutius; Liming Liang; Miriam Moffatt; William Cookson; Michael Kabesch; H-Erich Wichmann; Thomas Illig Journal: PLoS Genet Date: 2008-08-22 Impact factor: 5.917